TLI-0326

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameTLI-0326
Drug Alias NameTLI-0326
ClassificationSmall molecules
Mechanisms of ActionVoltage-gated calcium channel alpha2/delta subunit 1 modulatorsMu opioid receptor agonists
TargetsMu opioid receptorVoltage-gated calcium channel alpha2/delta subunit 1
Therapy Area/IndicationsPainDiabetic NeuropathiesFibromyalgia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsYes
Global Highest StatusPending (Clinical)
Highest Status in ChinaN/A
Originator CompaniesTrinity Laboratories Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesTrinity Laboratories Inc
Active IndicationsN/A
Inactive IndicationsPainDiabetic NeuropathiesFibromyalgia

Other Information

ATC CodeN/A
Related LinksN/A